Copyright
©2007 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 7, 2007; 13(41): 5481-5485
Published online Nov 7, 2007. doi: 10.3748/wjg.v13.i41.5481
Published online Nov 7, 2007. doi: 10.3748/wjg.v13.i41.5481
Characteristic | Entire cohort (n = 36) |
Female, n (%) | 24 (66.6%) |
Age (yr) | 47.9 ± 13.2 |
Estimated duration of HCV infection (mo) | 58 (24-120) |
HCV RNA (IU/mL) | 2471075 ± 2490186 |
Body mass index (kg/m2) | 28.5 ± 3.9 |
Waist Circumference (cm) | 98 ± 11 |
Fasting glucose (mg/dL) | 96 ± 10 |
Haemoglobin (mg/dL) | 13.9 ± 1.5 |
HOMA index | 3.1 ± 2.4 |
Total cholesterol (mg/dL) | 161 ± 36 |
HDL cholesterol (mg/dL) | 48 ± 11 |
Triglycerides (mg/dL) | 98 ± 41 |
Serum albumin (g/dL) | 4.4 ± 0.3 |
Serum globulin (g/dL) | 3.1 ± 0.6 |
Serum creatinine (mg/dL) | 0.8 ± 0.2 |
AST (IU/L) | 48 (32-67) |
ALT (IU/L) | 64 (34-80) |
ALP (IU/L) | 90 ± 33 |
GGT (IU/L) | 45 (29-63) |
LDH (IU/L) | 184 ± 32 |
Total Bilirubin (mg/dL) | 0.7 ± 0.3 |
Direct Bilirubin (mg/dL) | 0.3 (0.2-0.4) |
Platelet count (103/mm3) | 202 ± 54 |
Ferritin (ng/mL) | 45 (34-77) |
Positive ANA, n (%) | 2 (5.5%) |
Positive AMA, n | 0 |
Positive ASMA, n | 0 |
Positive LKM-1, n | 0 |
Variable | Score |
Hepatitis activity index | 9.5 ± 3.7 |
Periportal necrosis with or without bridging necrosis | 3.7 ± 2.2 |
Intralobular degeneration and focal necrosis | 2.7 ± 1.1 |
Portal inflammation | 3.0 ± 1.0 |
Fibrosis | 1.9 ± 1.2 |
- Citation: Akkaya O, Kiyici M, Yilmaz Y, Ulukaya E, Yerci O. Clinical significance of activity of ALT enzyme in patients with hepatitis C virus. World J Gastroenterol 2007; 13(41): 5481-5485
- URL: https://www.wjgnet.com/1007-9327/full/v13/i41/5481.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i41.5481